Skip to textbook content
Doctor’s PassportTextbook
TopicsAll topics

Loading topic navigation…

Textbook navigation
TopicsAll topics

Loading topic navigation…
Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.

Cardiac biomarkers and troponin interpretation

Cardiology · UK scope · Sources checked 27 Aug 2026 · Clinical review pending

RapidFull
!
Escalate

Do not wait for troponin when the ECG shows STEMI or there is ongoing ischaemia, shock or a life-threatening arrhythmia; activate urgent reperfusion or senior assessment immediately.

Synopsis

Interpret high-sensitivity troponin as a time-dependent marker of myocardial injury and integrate it with symptoms, ECG and the assay-specific pathway.

  • Cardiac troponin above the assay's 99th-centile upper reference limit defines myocardial injury, not its cause.
  • Acute injury requires a rise or fall; myocardial infarction additionally requires clinical evidence of acute ischaemia.
  • Use the validated sampling times and thresholds for the exact high-sensitivity assay in your laboratory.
  • A very early low result may not exclude infarction when symptoms began recently; repeat sampling is time- and assay-dependent.
  • Chronic kidney disease, heart failure and structural heart disease commonly produce persistent elevation, but acute coronary syndrome must still be assessed.
  • Type 2 myocardial infarction requires ischaemia from supply-demand imbalance; non-ischaemic acute injury is not type 2 MI.
  • CK-MB and myoglobin should not replace high-sensitivity cardiac troponin for routine ACS diagnosis.

Key red flags

STEMI despite pending biomarkers

Persistent diagnostic ST elevation with a compatible presentation is a reperfusion diagnosis; troponin delay can cost myocardium.

Investigation priorities

01
Serial high-sensitivity cardiac troponinFirst step

Detect or exclude acute myocardial injury.

Management branches

Preferred routeSuspected NSTE-ACS

Compatible symptoms without diagnostic persistent ST elevation

  1. Obtain ECG and first high-sensitivity troponin promptly, documenting symptom-onset time.
  2. Apply the exact assay's validated early rule-out or serial algorithm; repeat ECG and troponin if indicated.
  3. If acute injury and ischaemia coexist, diagnose MI and risk-stratify for invasive management.
  4. If ruled out, reassess the full differential and clinical risk before discharge.
Open full textbook →Answer 2 questionsCardiology check
Sources and review status4 sources · checked 27 Aug 2026 · clinical review pending+
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Apply principles in context and verify current guidance when a decision affects care. Source check completed 27 Aug 2026; clinical approval remains outstanding.

  • NICE HTG552: High-sensitivity troponin tests for early rule out of NSTEMI
  • NICE NG185: Acute coronary syndromes
  • ESC 2023 Guidelines for acute coronary syndromes
  • ESC 2018 Fourth Universal Definition of Myocardial Infarction

Editorial contact: Doctor’s Passport editorial team. Source-check date is separate from clinical approval. Report a content problem · Content changes

Authoring stateRapid draftClinical stateAwaiting reviewJurisdictionUnited Kingdom